Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Scientific References Long R3 insulin-like growth factor-1 (IGF-1) stimulates muscle cell hypertrophy Pharmacokinetics and tissue distribution of IGF-1 LR3 in preclinical models Long R3 insulin-like growth factor I (IGF-I) stimulates protein synthesis in muscle cells IGF-1 LR3: a potent analog with reduced binding to IGF-binding proteins
The secondary endpoint included changes in glucose, insulin, HOMA-IR, blood pressure, lipid profiles, uric acid, free fatty acids, hepatic profile, and the sensation of fatigue and hunger
In preclinical studies, compounds such as VX-765 and pralnacasan have demonstrated efficacy in inhibiting caspase-1 activation and protecting against inflammatory diseases
The IV drip is administered in-clinic under direct medical supervision, with monitoring throughout the 3060 minute session to ensure safety, comfort, and optimal response
US$ 25.99
US$ 23.86
US$ 21.43
US$ 27.31
US$ 22.86
US$ 21.37
